Latest Articles

03. 10. 2014

Notification concerning the establishment, the method of operation and the change of address of VPOIS

Notification concerning the establishment, the method of operation and the change of address of the Public Scientific Service (“VPOIS”) concerned with medicinal products.

 

30. 09. 2014

List of reimbursed medicinal products valid as of 1.10.2014

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

29. 08. 2014

List of reimbursed medicinal products valid as of 1.9.2014

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

11. 08. 2014

Centralised Procedure Documentation – change in submission to Czech NCA

The introduction of the Common Repository in February 2014 by European Medicines Agency has enabled Czech NCA to use the system as the only source of Centralised Procedure...

 

07. 07. 2014

Posting of clinical trial summary results in European Clinical Trials Database (EudraCT) to become mandatory

State Institute for Drug Control announces that the posting of summaries of clinical study results in the European Clinical Trials Database (EudraCT) becomes mandatory as...

 

03. 07. 2014

Correction of the List of reimbursed medicinal products valid as of 3.7.2014

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

30. 06. 2014

List of reimbursed medicinal products valid as of 1.7.2014

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

17. 06. 2014

Submission of Documentation via the CESP Portal

The State Institute for Drug Control (hereinafter referred to as the "Institute") hereby informs about the possibility to submit authorisation applications and related...